Gateway and journey of patients with cardiac amyloidosis
Abstract Aims Advances have been made over the last decade in the management of cardiac amyloidosis (CA), but a delayed diagnosis is still common. The aim of this study was to describe the journey to CA diagnosis from initial clinical and to analyse time to diagnosis. Methods and results Between Jan...
Main Authors: | Daniel Dang, Pauline Fournier, Eve Cariou, Antoine Huart, David Ribes, Pascal Cintas, Murielle Roussel, Magali Colombat, Yoan Lavie‐Badie, Didier Carrié, Michel Galinier, Olivier Lairez |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-10-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.12793 |
Similar Items
-
Impact of tricuspid regurgitation on survival in patients with cardiac amyloidosis
by: Jerome Fagot, et al.
Published: (2021-02-01) -
AL Amyloidosis
by: Desport Estelle, et al.
Published: (2012-08-01) -
Quantification of myocardial 99mTc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosis
by: Alain Manrique, et al.
Published: (2019-12-01) -
AMYLOIDOSIS HEART IN ELDERLY
by: L. I. Dvoretsky, et al.
Published: (2015-12-01) -
Can myocardial work indices contribute to the exploration of patients with cardiac amyloidosis?
by: Didier Carrié, et al.
Published: (2020-12-01)